The Pharma sector is currently going through a highly charged period especially in the regulatory realm. However, despite the uncertainty, the sector is poised to perform well in the coming period. The pharma companies engaged in niche markets are expected to push their R&D efforts further. Actinium Pharmaceuticals Inc. (NYSEMKT: ATNM) is one such …View the full post at: Actinium Pharmaceuticals (ATNM) Receives New Patents, Boosts Its Portfolio …
Related Articles:
Salesforce (CRM) is Going On An Acquisition Spree
Cameco (CCJ) – Uranium Stocks Recent Price Jump; Low Hanging Fruit or Trend?
Barrick Gold (ABX) – Billionaires Are Cornering the Gold Market
Using Amazon (AMZN) Options to Beat the Stock
